Suppr超能文献

四氯化碳诱导肝硬化大鼠肝脏微粒体药物代谢中的限速步骤。

Rate-limiting steps in drug metabolism by microsomes from CCl-4-cirrhotic rat liver.

作者信息

Tsyrlov I B, Lyakhovich V V

出版信息

Chem Biol Interact. 1975 Feb;10(2):77-89. doi: 10.1016/0009-2797(75)90102-7.

Abstract

Comparative studies have been conducted of the activity of microsomal mixed-function oxidases from livers of normal, precirrhotic and cirrhotic rats linked with the metabolism of type-I (aminopyrine, hexobarbital), type-II (aniline, metyrapone) and "modified type-II" (corticosterone) substrates. The following factors were investigated: the possible role of cytochrome P-450 content, the state of the "substrate-binding protein" of this enzyme, the degree of affinity of this hemoprotein for both type-I and type-II substrates and finally, the activity of the enzymes of the microsomal electron-transport chain (both in the absence and in the presence of type-I substrate) -- as rate-limiting reactions, "tight spots" in the biotransformation of drugs in experimental microsomes. It was found that the hydroxylation activity for type-II and "modified type-II" substrates during the entire period of liver cirrhosis development is determined by the cytochrome P-450 content and the amplitude of maximal spectral changes observed in the presence of excess substrate. Type-I substrate metabolism, however, is limited in the precirrhotic phase by the state of the "substrate-binding protein" contained in P-450 as well as by the NADPH-cytochrome P-450 reductase activity. On the other hand, the N-demethylating activity in CCl-4-cirrhotic liver microsomes does not depend on either the concentration of P-450, on the amplitude of the maximal spectral changes or on the Ks value. The rate-limiting step in this case is the rate of reduction of the P-450-substrate complex by NADPH.

摘要

已对正常、肝硬化前期和肝硬化大鼠肝脏微粒体混合功能氧化酶的活性进行了比较研究,这些酶与I型(氨基比林、己巴比妥)、II型(苯胺、甲吡酮)和“改良II型”(皮质酮)底物的代谢相关。研究了以下因素:细胞色素P - 450含量的可能作用、该酶的“底物结合蛋白”状态、这种血红蛋白对I型和II型底物的亲和程度,以及最后微粒体电子传递链酶的活性(在不存在和存在I型底物的情况下)——作为限速反应,即实验性微粒体中药物生物转化的“瓶颈”。结果发现,在肝硬化发展的整个过程中,II型和“改良II型”底物的羟化活性由细胞色素P - 450含量以及在过量底物存在下观察到的最大光谱变化幅度决定。然而,I型底物代谢在肝硬化前期阶段受到P - 450中所含“底物结合蛋白”状态以及NADPH - 细胞色素P - 450还原酶活性的限制。另一方面,四氯化碳诱导的肝硬化肝脏微粒体中的N - 脱甲基活性既不依赖于P - 450的浓度、最大光谱变化的幅度,也不依赖于Ks值。在这种情况下,限速步骤是NADPH对P - 450 - 底物复合物的还原速率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验